NIH Just Rebuilt COBRE's Phase Ladder. The First Applications Under the New Structure Are Due September 25 — and One Sentence Decides Which Track You Are On.

The Centers of Biomedical Research Excellence program has run on the same architecture since the late 1990s: three sequential five-year phases, Phase 1 through Phase 3, fifteen years of NIH support to build a research center at an institution in a state that historically does not get much NIH money. Everyone in the IDeA states knows the ladder. Careers have been planned around it.

That ladder is gone. In its place, the National Institute of General Medical Sciences has issued two notices of funding opportunity — PAR-27-054 and PAR-27-055 — that restructure COBRE into named phases on two distinct tracks. The first application due date under the new structure is September 25, 2026.

This is not a rebranding. The new structure changes who is eligible for what, how long an institution can be supported, what it can build in the final phase, and — most importantly — it forces every applicant to make a self-assessment that determines whether they get fifteen years of support or ten.

The two tracks

The D-E-S track — Development, Expansion, Sustainability — runs three consecutive five-year phases for up to 15 years of total support. It is for institutions with no existing research capacity in the proposed area. The Development phase (COBRE-D, PAR-27-054) recruits early-career faculty, builds startup packages, establishes facilities, and strengthens research administration. Expansion grows the faculty base and the core facilities. Sustainability consolidates so the center survives the end of COBRE money.

The E-S track — Expansion, Sustainability — runs two consecutive five-year phases for up to 10 years. It is for institutions that already have foundational capacity in the proposed area and are scaling an existing effort rather than starting from nothing.

Both Expansion and Sustainability phases are covered by a single NOFO, PAR-27-055, posted June 18, 2026. COBRE-D was posted August 19, 2026.

The consequential sentence in PAR-27-055 is the eligibility condition for the Expansion phase: an applicant needs either existing research capacity in the proposed area or an active Phase 1 / COBRE-D award. The Sustainability phase requires an active Phase 2 or COBRE-E award.

Read as an institution, that means two things. If you hold a legacy Phase 1 award, you are grandfathered into COBRE-E and the D-E-S ladder continues under new names. If you hold no COBRE award but have real capacity in the area, you can enter directly at Expansion — and in doing so you forfeit five years and one full phase of funding. The entry point you claim is a permanent, irreversible decision about the ceiling on your support.

What the money actually is

The Expansion and Sustainability phases carry an annual budget ceiling of $1.5 million in direct costs, exclusive of facilities and administrative costs, over a five-year project period. There is no cost sharing requirement.

For an institution in an IDeA state, $1.5 million per year in direct costs is a large number in a way that is easy to underestimate from the outside. It is enough to fund a mentored cohort of early-career investigators, an administrative core, and a scientific research program simultaneously — the kind of package that, at a research-intensive institution, would be assembled from six or eight separate R01s and a departmental commitment. COBRE is one of the very few NIH mechanisms that funds institutional capacity rather than a specific hypothesis, and that is precisely why the phase structure matters so much: it is the only NIH award where the thing being built is the ability to compete for other NIH awards.

The cores rule is the biggest practical change

Under the new structure, research cores are optional during the Expansion phase, and new cores are prohibited entirely during the Sustainability phase. PAR-27-055 makes the reasoning explicit: NIGMS now emphasizes "consolidation and sharing of research facilities supported by other IDeA programs" rather than establishing new, redundant cores.

This inverts a long-standing incentive. Under the old model, a center could reasonably plan to add capability as it matured — Phase 1 recruits people, Phase 2 builds a core, Phase 3 builds another. The new model says the opposite: every core your center will ever have must be justified and built by the end of Expansion. Sustainability is a consolidation phase, not a growth phase.

If you are writing a COBRE-E application for September 25, the strategic implication is immediate and expensive. Your core facility plan is no longer a five-year plan — it is a ten-year plan that you have to get right now, because there is no second bite. And it must be written against a landscape that includes cores already funded by INBRE and IDeA-CTR awards in your state. A reviewer looking at a proposed new core will ask, first, whether an existing IDeA-supported facility within reach could do the same work. You need that answer in the application, in writing, with names.

Eligibility: 23 states, Puerto Rico, and a hard cap of three

The IDeA program covers 23 states plus Puerto Rico: Alaska, Arkansas, Delaware, Hawaii, Idaho, Kansas, Kentucky, Louisiana, Maine, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oklahoma, Rhode Island, South Carolina, South Dakota, Vermont, West Virginia, and Wyoming.

Eligible institutions must be public or private institutions of higher education, or nonprofits with or without 501(c)(3) status, and must award doctoral degrees in health-related sciences or operate as independent biomedical research institutes with existing NIH or other federal funding.

Then the constraint that shapes the whole competition: applications are limited to institutions holding three or fewer active COBRE awards at submission.

This is a deliberate redistribution. In several IDeA states, COBRE funding has concentrated at the flagship university, which accumulated awards across decades while smaller institutions in the same state built nothing. A three-award cap tells the flagship it is done adding centers and tells everyone else that the competitive field just thinned. If you are at a regional public university or an independent research institute in an IDeA state and you have looked at COBRE before and concluded the state flagship would always win, that calculation has changed, and it changed in a NOFO most people have not read.

Count carefully before you write. "Active" includes awards in no-cost extension. An institution at three active awards that expects one to close in FY2027 is eligible for the January or May 2027 cycles, not September 2026.

The application calendar is a standing one, and that changes the strategy

PAR-27-055 is not a one-shot competition. It carries recurring due dates through the life of the NOFO:

• September 25, 2026
• January 25, 2027
• May 25, 2027
• September 25, 2027
• January 25, 2028
• May 25, 2028
• September 25, 2028
• January 25, 2029
• May 25, 2029

Expiration: May 26, 2029.

Three cycles a year for nearly three years is unusually generous by NIH center-grant standards, and it fits the broader pattern we described when NIH consolidated hundreds of narrow NOFOs into broader standing announcements and began piloting plain-language SimplerNOFO formats.

The strategic consequence of a standing NOFO is counterintuitive: it lowers the cost of waiting and raises the cost of a weak first submission. A COBRE application is a months-long institutional effort involving a center director, multiple project leaders, a mentoring plan, and letters of institutional commitment. Submitting an underdeveloped version to hit September 25 when January 25 is four months away is almost never the right call — and under the new phase rules, a rushed application that misidentifies your track is worse than no application at all, because it puts a written institutional self-assessment in front of a study section that will still be visible when you come back.

The one thing that argues for September 25: it is the first cycle. Review panels seeing the first batch of applications under a restructured program have no established comparison set. That is worth something to a strong application and nothing to a marginal one.

What a competitive application looks like under the new rules

PAR-27-055 requires four components, three of them mandatory:

1. Overall plan with an explicit sustainability strategy — required
2. Administrative Core — required
3. Scientific Research Program — required
4. Research Cores — optional in Expansion, and new cores prohibited in Sustainability

The elevation of the sustainability strategy from a section people wrote at the end to a mandatory, named component of the Overall plan is the tell. Review criteria include significance measured against institutional capacity expansion, investigator qualifications and mentoring commitment, innovation, organizational management and sustainability approaches, and research environment and institutional support.

Translating that into what actually wins:

Name the people. COBRE reviews turn on the early-career investigators being supported, not on the center director's own record. A COBRE-E application whose project leaders are three assistant professors with credible five-year paths to R01 independence beats one built around senior faculty every time. The mechanism exists to manufacture independent investigators; write it as if that is the deliverable, because it is.

Make institutional commitment financial and specific. "The institution is committed to sustaining this center" is not a sustainability strategy. A named line in the institutional budget, a signed commitment to convert two positions to hard money in year four, and a core facility recharge model with actual projected rates is a sustainability strategy. Under the new structure, where Sustainability is explicitly the last phase and NIGMS states the goal is continuation beyond COBRE support, this section carries more review weight than it did.

Address the IDeA ecosystem directly. Your state has an INBRE. It likely has an IDeA-CTR. If your application does not explain how your center relates to both — what it uses, what it does not duplicate, what it adds — a reviewer will read it as an institution that does not know its own state's research infrastructure.

Choose your track and defend it. If you are claiming existing capacity to enter at Expansion, document it with publications, existing extramural funding in the area, and named faculty. If you are claiming no capacity to enter at Development, do not undercut it three pages later by describing a thriving research group in the same area. The self-assessment has to be internally consistent across the whole application, and inconsistency here reads as an institution trying to game the ladder.

The context nobody in the IDeA states can ignore

This restructuring lands in the middle of the worst year for NIH extramural funding in recent memory. The agency has awarded a small fraction of its normal volume of new and competing grants, faces a September 30 obligation cliff on more than a billion dollars, and enters FY2027 under a continuing resolution.

For institutions in the 23 IDeA states, the contraction cuts differently than it does at the coastal research universities. A flagship with 400 active NIH grants absorbs a 30 percent decline in new awards as a bad year. An institution with eleven NIH grants, four of them in one COBRE, experiences the same percentage as an existential threat to a department. Capacity-building money is the buffer, and it is congressionally mandated — the IDeA program exists because Congress requires it, which makes it structurally more durable than programs that survive on agency discretion.

That durability is the underrated feature of this whole announcement. In a year when discretionary NIH programs are being restructured, delayed, and in some cases eliminated, NIGMS just published a standing COBRE NOFO with nine due dates running to May 2029 and a $1.5 million annual ceiling. That is a three-year commitment made in a policy environment where almost nothing else is committed three years out.

If your institution is in an IDeA state and has fewer than three active COBRE awards, the question is not whether to apply. It is which track you can honestly claim, whether your cores plan survives the ten-year test, and whether September 25 or January 25 gives you the application you actually want reviewed.

If you are mapping which NIH capacity-building mechanisms fit your institution — and which of the nine COBRE cycles between now and 2029 you should be building toward — Granted can help you sort the federal landscape into a short list worth the effort.